1. Home
  2. AMSC vs IOVA Comparison

AMSC vs IOVA Comparison

Compare AMSC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Superconductor Corporation

AMSC

American Superconductor Corporation

N/A

Current Price

$27.70

Market Cap

1.7B

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$10.16

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMSC
IOVA
Founded
1987
2007
Country
United States
United States
Employees
400
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2012
2008

Fundamental Metrics

Financial Performance
Metric
AMSC
IOVA
Price
$27.70
$10.16
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$52.00
$9.00
AVG Volume (30 Days)
596.7K
13.0M
Earning Date
05-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
1806.25
14.84
EPS
0.20
N/A
Revenue
$900,000.00
N/A
Revenue This Year
$34.98
$47.74
Revenue Next Year
$21.38
$40.31
P/E Ratio
$138.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.87
$1.76
52 Week High
$70.49
$9.36

Technical Indicators

Market Signals
Indicator
AMSC
IOVA
Relative Strength Index (RSI) 39.57 70.70
Support Level $26.88 $3.82
Resistance Level $33.70 N/A
Average True Range (ATR) 1.02 0.42
MACD 0.01 -0.01
Stochastic Oscillator 14.47 86.11

Price Performance

Historical Comparison
AMSC
IOVA

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: